Disparities Details by Country of Birth for 2016
IID-11.4 : Female adolescents receiving 2 or 3 doses of HPV vaccine by age 13–15 years (percent)
This chart compares rates by population.
Error Bar (I) represents the 95% confidence interval.
Additional footnotes may apply to these data. Please refer to footnotes below the data table for further information.
See also Disparities Overview by Country of Birth for IID-11.4
IID-11.4 Increase the percentage of female adolescents aged 13 through 15 years who receive 2 or 3 doses of human papillomavirus (HPV) vaccine as recommended
Female adolescents receiving 2 or 3 doses of HPV vaccine by age 13–15 years (percent)
|Country of Birth||2016 1||Disparity|
|Outside US|| 49.3
1 Baseline has been revised. See Data Details for more information.
Data are subject to revision and may have changed since a previous release.
Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.
Data are not available or not collected for populations not shown.
CI: 95% confidence interval.
- The better group rate for this objective, 49.3%, was attained by persons who were born outside the US.
- The worse group rate for this objective, 44.9%, was attained by persons who were born in the US.
- The absolute difference (or range) between the best and worst group rates was 4.3 percentage points.
- The best group rate was <1.100 times the worst group rate.
Persons born outside the US achieved the better group rate for this objective, 49.3%.
The better group rate was <1.1 times the rate among persons born in the US.